WHO_REGION,UNICEF_REGION,WBINCOME_SHORT_STATUS,WHO_LEGAL_STATUS_TITLE,DEVELOPMENT_STATUS,COVAX_STATUS,COUNTRYNAME,ISO_3_CODE,MONTH_DESCRIPTION,PROCUREMENT_TYPE,MANUFACTURER_DESCRIPTION,VACCINE_NAME,TOTAL_DOSES
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,59000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,59000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,81000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,1000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-05-04T23:00:00.000Z,DONATION,Serum Institute of India,AstraZeneca - Vaxzevria,59000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-06-05T23:00:00.000Z,DONATION,Julphar,Julphar - Hayat-Vax,25000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-10-09T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,131120
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-10-09T23:00:00.000Z,DONATION,Chumakov,Gamaleya - Gam-Covid-Vac,1000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-10-09T23:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,35100
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-10-09T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,59000
AFR,ESARO,High income,Member State,Developing,No,Seychelles,SYC,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,226220
AFR,ESARO,Low income,Member State,Least developed,AMC,Burundi,BDI,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Beijing CNBG - BBIBP-CorV,500000
AFR,ESARO,Low income,Member State,Least developed,AMC,Burundi,BDI,2022-11-11T00:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,151200
AFR,ESARO,Low income,Member State,Least developed,AMC,Burundi,BDI,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,651200
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,3493200
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,2779440
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,3493200
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,4963440
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,2729750
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1552200
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,2184000
AFR,ESARO,Low income,Member State,Least developed,AMC,Ethiopia,ETH,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,8456640
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,250000
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,468000
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
AFR,ESARO,Low income,Member State,Least developed,AMC,Madagascar,MDG,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,50000
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,50000
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,1787390
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,638400
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-06-05T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,102000
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-07-06T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,102000
AFR,ESARO,Low income,Member State,Least developed,AMC,Malawi,MWI,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,2425790
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,100000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,11000000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Wuhan Institute of Biological Products (CNBG),Wuhan CNBG - Inactivated,260000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Wuhan CNBG - Inactivated,2960000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,302400
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,302400
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,384000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,642000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-06-05T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,100000
AFR,ESARO,Low income,Member State,Least developed,AMC,Mozambique,MOZ,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,3904400
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,3983850
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-06-05T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,52960
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,1083090
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,420060
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,10000
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,2000
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,604400
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,108000
AFR,ESARO,Low income,Member State,Least developed,AMC,Rwanda,RWA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,6211400
AFR,ESARO,Low income,Member State,Least developed,AMC,South Sudan,SSD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,119520
AFR,ESARO,Low income,Member State,Least developed,AMC,South Sudan,SSD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,152950
AFR,ESARO,Low income,Member State,Least developed,AMC,South Sudan,SSD,2022-06-05T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,60000
AFR,ESARO,Low income,Member State,Least developed,AMC,South Sudan,SSD,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,272470
AFR,ESARO,Low income,Member State,Least developed,AMC,Uganda,UGA,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,100000
AFR,ESARO,Low income,Member State,Least developed,AMC,Uganda,UGA,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,864000
AFR,ESARO,Low income,Member State,Least developed,AMC,Uganda,UGA,2022-06-05T23:00:00.000Z,NR,NR,All vaccine types,964000
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,175190
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,302400
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,0
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,100620
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-11-11T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,302400
AFR,ESARO,Middle income,Member State,Developing,AMC,Eswatini,SWZ,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,403020
AFR,ESARO,Middle income,Member State,Developing,AMC,Kenya,KEN,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,100000
AFR,ESARO,Middle income,Member State,Developing,AMC,Kenya,KEN,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,880460
AFR,ESARO,Middle income,Member State,Developing,AMC,Kenya,KEN,2022-04-03T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,1020000
AFR,ESARO,Middle income,Member State,Developing,AMC,Kenya,KEN,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,3088300
AFR,ESARO,Middle income,Member State,Developing,AMC,Kenya,KEN,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,3968760
AFR,ESARO,Middle income,Member State,Developing,AMC,Zimbabwe,ZWE,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,5492800
AFR,ESARO,Middle income,Member State,Developing,AMC,Zimbabwe,ZWE,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Bharat Biotech,Bharat - Covaxin,35000
AFR,ESARO,Middle income,Member State,Developing,AMC,Zimbabwe,ZWE,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,6200000
AFR,ESARO,Middle income,Member State,Developing,AMC,Zimbabwe,ZWE,2022-08-07T23:00:00.000Z,NR,NR,All vaccine types,11727800
AFR,ESARO,Middle income,Member State,Developing,No,Namibia,NAM,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,30000
AFR,ESARO,Middle income,Member State,Developing,No,Namibia,NAM,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,350000
AFR,ESARO,Middle income,Member State,Developing,No,Namibia,NAM,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,247200
AFR,ESARO,Middle income,Member State,Developing,No,Namibia,NAM,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,597200
AFR,ESARO,Middle income,Member State,Developing,No,South Africa,ZAF,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,500000
AFR,ESARO,Middle income,Member State,Developing,No,South Africa,ZAF,2022-05-04T23:00:00.000Z,NR,NR,All vaccine types,500000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,40000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,19890
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,400000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,130800
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-07-06T23:00:00.000Z,MULTILATERAL_AFRICAN,Sinovac,Sinovac - CoronaVac,400000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,108000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Botswana,BWA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,658690
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Mauritius,MUS,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,200000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Mauritius,MUS,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,262400
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Mauritius,MUS,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,600000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Mauritius,MUS,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Bharat Biotech,Bharat - Covaxin,200000
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Mauritius,MUS,2022-04-03T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,62800
AFR,ESARO,Middle income,Member State,Developing,Self-financing,Mauritius,MUS,2022-06-05T23:00:00.000Z,NR,NR,All vaccine types,1062400
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,200000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,588550
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,4674130
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,3049650
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,3352800
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,6027840
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Sinovac,Beijing CNBG - BBIBP-CorV,15089622
AFR,ESARO,Middle income,Member State,Least developed,AMC,Angola,AGO,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,32782592
AFR,ESARO,Middle income,Member State,Least developed,AMC,Comoros,COM,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,100000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Comoros,COM,2022-04-03T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,
AFR,ESARO,Middle income,Member State,Least developed,AMC,Comoros,COM,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,12000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Comoros,COM,2022-06-05T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,6000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Comoros,COM,2022-06-05T23:00:00.000Z,NR,NR,All vaccine types,118000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Lesotho,LSO,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,200000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Lesotho,LSO,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,72000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Lesotho,LSO,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,659600
AFR,ESARO,Middle income,Member State,Least developed,AMC,Lesotho,LSO,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,72000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Lesotho,LSO,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,931600
AFR,ESARO,Middle income,Member State,Least developed,AMC,United Republic of Tanzania,TZA,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,1000
AFR,ESARO,Middle income,Member State,Least developed,AMC,United Republic of Tanzania,TZA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1065600
AFR,ESARO,Middle income,Member State,Least developed,AMC,United Republic of Tanzania,TZA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,110000
AFR,ESARO,Middle income,Member State,Least developed,AMC,United Republic of Tanzania,TZA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1058400
AFR,ESARO,Middle income,Member State,Least developed,AMC,United Republic of Tanzania,TZA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,2234000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,113600
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,113600
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-08-07T23:00:00.000Z,COVAX_FACILITY,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,432000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,119200
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,228000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,410100
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,636000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,638400
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1008000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,188400
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,580320
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,228000
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,604800
AFR,ESARO,Middle income,Member State,Least developed,AMC,Zambia,ZMB,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,4754820
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,50000
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,700000
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,1000000
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,604800
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,22975200
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,2253200
AFR,MENA,Middle income,Member State,Developing,AMC,Algeria,DZA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,27533200
AFR,WCARO,Low income,Member State,Least developed,AMC,Burkina Faso,BFA,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,115000
AFR,WCARO,Low income,Member State,Least developed,AMC,Burkina Faso,BFA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,1074000
AFR,WCARO,Low income,Member State,Least developed,AMC,Burkina Faso,BFA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,222800
AFR,WCARO,Low income,Member State,Least developed,AMC,Burkina Faso,BFA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,453860
AFR,WCARO,Low income,Member State,Least developed,AMC,Burkina Faso,BFA,2022-04-03T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,115200
AFR,WCARO,Low income,Member State,Least developed,AMC,Burkina Faso,BFA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1750660
AFR,WCARO,Low income,Member State,Least developed,AMC,Central African Republic,CAF,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,35000
AFR,WCARO,Low income,Member State,Least developed,AMC,Central African Republic,CAF,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,150000
AFR,WCARO,Low income,Member State,Least developed,AMC,Central African Republic,CAF,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,163160
AFR,WCARO,Low income,Member State,Least developed,AMC,Central African Republic,CAF,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,638400
AFR,WCARO,Low income,Member State,Least developed,AMC,Central African Republic,CAF,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,951560
AFR,WCARO,Low income,Member State,Least developed,AMC,Chad,TCD,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,200000
AFR,WCARO,Low income,Member State,Least developed,AMC,Chad,TCD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,333450
AFR,WCARO,Low income,Member State,Least developed,AMC,Chad,TCD,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,533450
AFR,WCARO,Low income,Member State,Least developed,AMC,Democratic Republic of the Congo,COD,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,400000
AFR,WCARO,Low income,Member State,Least developed,AMC,Democratic Republic of the Congo,COD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,527840
AFR,WCARO,Low income,Member State,Least developed,AMC,Democratic Republic of the Congo,COD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,756000
AFR,WCARO,Low income,Member State,Least developed,AMC,Democratic Republic of the Congo,COD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,250320
AFR,WCARO,Low income,Member State,Least developed,AMC,Democratic Republic of the Congo,COD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,250000
AFR,WCARO,Low income,Member State,Least developed,AMC,Democratic Republic of the Congo,COD,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,2184160
AFR,WCARO,Low income,Member State,Least developed,AMC,Gambia,GMB,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,355200
AFR,WCARO,Low income,Member State,Least developed,AMC,Gambia,GMB,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,89400
AFR,WCARO,Low income,Member State,Least developed,AMC,Gambia,GMB,2022-06-05T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,15000
AFR,WCARO,Low income,Member State,Least developed,AMC,Gambia,GMB,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Sinovac,Sinovac - CoronaVac,10000
AFR,WCARO,Low income,Member State,Least developed,AMC,Gambia,GMB,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,454600
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,300000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,1678000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,569160
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,2100000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,2101000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,97990
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,194400
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,407990
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,444000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,588510
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,399360
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,Sinovac - CoronaVac,708000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,300000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-07-06T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,69000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,336000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Serum Institute of India,SII - Covishield,69000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,4298860
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea,GIN,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,4410660
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,173600
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,302400
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,306070
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-04-03T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,28800
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-07-06T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,25787
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-07-06T23:00:00.000Z,MULTILATERAL_AFRICAN,Sinovac,Sinovac - CoronaVac,6000
AFR,WCARO,Low income,Member State,Least developed,AMC,Guinea-Bissau,GNB,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,782070
AFR,WCARO,Low income,Member State,Least developed,AMC,Liberia,LBR,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,315000
AFR,WCARO,Low income,Member State,Least developed,AMC,Liberia,LBR,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,578600
AFR,WCARO,Low income,Member State,Least developed,AMC,Liberia,LBR,2022-06-05T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,27000
AFR,WCARO,Low income,Member State,Least developed,AMC,Liberia,LBR,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,893600
AFR,WCARO,Low income,Member State,Least developed,AMC,Mali,MLI,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,396000
AFR,WCARO,Low income,Member State,Least developed,AMC,Mali,MLI,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,79200
AFR,WCARO,Low income,Member State,Least developed,AMC,Mali,MLI,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,151200
AFR,WCARO,Low income,Member State,Least developed,AMC,Mali,MLI,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,835200
AFR,WCARO,Low income,Member State,Least developed,AMC,Mali,MLI,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1461600
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,25000
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,425000
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,1123600
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Wuhan CNBG - Inactivated,0
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-06-05T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,AstraZeneca - Vaxzevria,
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,0
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Wuhan CNBG - Inactivated,
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,0
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,0
AFR,WCARO,Low income,Member State,Least developed,AMC,Niger,NER,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,0
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,240000
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,440000
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,234000
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,336000
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,113490
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-05-04T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,42000
AFR,WCARO,Low income,Member State,Least developed,AMC,Sierra Leone,SLE,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1123490
AFR,WCARO,Low income,Member State,Least developed,AMC,Togo,TGO,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,1427200
AFR,WCARO,Low income,Member State,Least developed,AMC,Togo,TGO,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,599360
AFR,WCARO,Low income,Member State,Least developed,AMC,Togo,TGO,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,707850
AFR,WCARO,Low income,Member State,Least developed,AMC,Togo,TGO,2022-06-05T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,120000
AFR,WCARO,Low income,Member State,Least developed,AMC,Togo,TGO,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,592800
AFR,WCARO,Low income,Member State,Least developed,AMC,Togo,TGO,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,3327210
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,50000
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,559200
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,55200
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,100100
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,5850
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,50000
AFR,WCARO,Middle income,Member State,Developing,AMC,Cabo Verde,CPV,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,715150
AFR,WCARO,Middle income,Member State,Developing,AMC,Cameroon,CMR,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,200000
AFR,WCARO,Middle income,Member State,Developing,AMC,Cameroon,CMR,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,391200
AFR,WCARO,Middle income,Member State,Developing,AMC,Cameroon,CMR,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,461450
AFR,WCARO,Middle income,Member State,Developing,AMC,Cameroon,CMR,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1052650
AFR,WCARO,Middle income,Member State,Developing,AMC,Congo,COG,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,141220
AFR,WCARO,Middle income,Member State,Developing,AMC,Congo,COG,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,134000
AFR,WCARO,Middle income,Member State,Developing,AMC,Congo,COG,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,609220
AFR,WCARO,Middle income,Member State,Developing,AMC,Congo,COG,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,355200
AFR,WCARO,Middle income,Member State,Developing,AMC,Congo,COG,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1098420
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,50000
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,SII - Covishield,75000
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1654380
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-05-04T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,SII - Covishield,654000
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,2373890
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,2845271
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-11-11T00:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
AFR,WCARO,Middle income,Member State,Developing,AMC,Côte d'Ivoire,CIV,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,52000
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,AstraZeneca - Vaxzevria,2000
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,21000
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-04-03T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,AstraZeneca - Vaxzevria,600000
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,3598770
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,1229620
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1330290
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-04-03T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,314850
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,737200
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1178450
AFR,WCARO,Middle income,Member State,Developing,AMC,Ghana,GHA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,8095330
AFR,WCARO,Middle income,Member State,Developing,AMC,Nigeria,NGA,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,100000
AFR,WCARO,Middle income,Member State,Developing,AMC,Nigeria,NGA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1911600
AFR,WCARO,Middle income,Member State,Developing,AMC,Nigeria,NGA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,8794240
AFR,WCARO,Middle income,Member State,Developing,AMC,Nigeria,NGA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,4000080
AFR,WCARO,Middle income,Member State,Developing,AMC,Nigeria,NGA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,3577860
AFR,WCARO,Middle income,Member State,Developing,AMC,Nigeria,NGA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,18283780
AFR,WCARO,Middle income,Member State,Developing,No,Equatorial Guinea,GNQ,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,820000
AFR,WCARO,Middle income,Member State,Developing,No,Equatorial Guinea,GNQ,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,820000
AFR,WCARO,Middle income,Member State,Developing,No,Gabon,GAB,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,10000
AFR,WCARO,Middle income,Member State,Developing,No,Gabon,GAB,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,400000
AFR,WCARO,Middle income,Member State,Developing,No,Gabon,GAB,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,168000
AFR,WCARO,Middle income,Member State,Developing,No,Gabon,GAB,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,100620
AFR,WCARO,Middle income,Member State,Developing,No,Gabon,GAB,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,668620
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,144000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,203000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-07-06T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,203000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,144000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,410400
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,332280
AFR,WCARO,Middle income,Member State,Least developed,AMC,Benin,BEN,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1089680
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,437140
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,302400
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,922350
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,204150
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,410400
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,104130
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,738000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-04-03T23:00:00.000Z,MULTILATERAL_AFRICAN,AstraZeneca,AstraZeneca - Vaxzevria,27000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Mauritania,MRT,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,2174880
AFR,WCARO,Middle income,Member State,Least developed,AMC,Sao Tome and Principe,STP,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,49000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Sao Tome and Principe,STP,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,100000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Sao Tome and Principe,STP,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,48500
AFR,WCARO,Middle income,Member State,Least developed,AMC,Sao Tome and Principe,STP,2022-09-08T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,79200
AFR,WCARO,Middle income,Member State,Least developed,AMC,Sao Tome and Principe,STP,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,276700
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,200000
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,1768260
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,796800
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-06-05T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,AstraZeneca - Vaxzevria,
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,265590
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,1109318
AFR,WCARO,Middle income,Member State,Least developed,AMC,Senegal,SEN,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,3939968
AMR,,High income,Territory or Area,Developing,,Bermuda,BMU,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,26400
AMR,,High income,Territory or Area,Developing,,Bermuda,BMU,2022-07-06T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
AMR,,High income,Territory or Area,Developing,,Bermuda,BMU,2022-07-06T23:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
AMR,,High income,Territory or Area,Developing,,Bermuda,BMU,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,26400
AMR,Dev,High income,Member State,Developed economy,No,United States of America,USA,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,600000000
AMR,Dev,High income,Member State,Developed economy,No,United States of America,USA,2022-07-06T23:00:00.000Z,OTHER,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,100000000
AMR,Dev,High income,Member State,Developed economy,No,United States of America,USA,2022-07-06T23:00:00.000Z,OTHER,Moderna,Moderna - Spikevax,300000000
AMR,Dev,High income,Member State,Developed economy,No,United States of America,USA,2022-07-06T23:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,200000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,Unknown Vaccine,20000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,Unknown Vaccine,20000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,20000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,38000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Medicago Inc,Medicago - VLP,76000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,44000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Novavax,Novavax - Covavax,76000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,76000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Sanofi Pasteur - GSK,Sanofi GSK - Vidprevtyn,72000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,AstraZeneca - Vaxzevria,2000000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-03-03T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,Unknown Vaccine,1624800
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,1624800
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-03-03T00:00:00.000Z,DONATION,AstraZeneca,Unknown Vaccine,1500000
AMR,Dev,High income,Member State,Developed economy,Self-financing,Canada,CAN,2022-08-07T23:00:00.000Z,NR,NR,All vaccine types,405624800
AMR,LACRO,,Territory or Area,Developing,,Anguilla,AIA,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,24010
AMR,LACRO,,Territory or Area,Developing,,Anguilla,AIA,2022-12-12T00:00:00.000Z,OTHER,AstraZeneca,AstraZeneca - Vaxzevria,20500
AMR,LACRO,,Territory or Area,Developing,,Anguilla,AIA,2022-12-12T00:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,3510
AMR,LACRO,High income,Territory or Area,Developing,,British Virgin Islands,VGB,2022-05-04T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,38000
AMR,LACRO,High income,Territory or Area,Developing,,British Virgin Islands,VGB,2022-05-04T23:00:00.000Z,NR,NR,All vaccine types,38000
AMR,LACRO,High income,Member State,Developing,Self-financing,Antigua and Barbuda,ATG,2022-07-06T23:00:00.000Z,DONATION,Serum Institute of India,AstraZeneca - Vaxzevria,5000
AMR,LACRO,High income,Member State,Developing,Self-financing,Antigua and Barbuda,ATG,2022-09-08T23:00:00.000Z,DONATION,AnGes Biopharmaceutical,Pfizer BioNTech - Comirnaty,17500
AMR,LACRO,High income,Member State,Developing,Self-financing,Antigua and Barbuda,ATG,2022-09-08T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,12000
AMR,LACRO,High income,Member State,Developing,Self-financing,Antigua and Barbuda,ATG,2022-09-08T23:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,38500
AMR,LACRO,High income,Member State,Developing,Self-financing,Antigua and Barbuda,ATG,2022-09-08T23:00:00.000Z,DONATION,Vaxxinity Inc,Gamaleya - Sputnik-Light,2000
AMR,LACRO,High income,Member State,Developing,Self-financing,Antigua and Barbuda,ATG,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,70000
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,30000
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,100800
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,14040
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,60000
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,30000
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,140200
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,90000
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,472040
AMR,LACRO,High income,Member State,Developing,Self-financing,Barbados,BRB,2022-12-12T00:00:00.000Z,OTHER,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,7000
AMR,LACRO,High income,Member State,Developing,Self-financing,Chile,CHL,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,CanSino Biologicals,CanSino - Convidecia,300000
AMR,LACRO,High income,Member State,Developing,Self-financing,Chile,CHL,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,2589600
AMR,LACRO,High income,Member State,Developing,Self-financing,Chile,CHL,2022-05-04T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,489600
AMR,LACRO,High income,Member State,Developing,Self-financing,Chile,CHL,2022-05-04T23:00:00.000Z,MULTILATERAL_OTHER,Sinovac,Sinovac - CoronaVac,17100000
AMR,LACRO,High income,Member State,Developing,Self-financing,Chile,CHL,2022-05-04T23:00:00.000Z,NR,NR,All vaccine types,20479200
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-04-03T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,21600
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,41500
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-06-05T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,5000
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-06-05T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,20000
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,SII - Covishield,5000
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-12-12T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,11700
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,79800
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-06-05T23:00:00.000Z,OTHER,AstraZeneca,AstraZeneca - Vaxzevria,21600
AMR,LACRO,High income,Member State,Developing,Self-financing,Saint Kitts and Nevis,KNA,2022-12-12T00:00:00.000Z,OTHER,AstraZeneca,SII - Covishield,21600
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,67200
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,26000
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,100000
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,DONATION,Bharat Biotech,Pfizer BioNTech - Comirnaty,305770
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,27000
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,800000
AMR,LACRO,High income,Member State,Developing,Self-financing,Trinidad and Tobago,TTO,2022-08-07T23:00:00.000Z,NR,NR,All vaccine types,1325970
AMR,LACRO,High income,Member State,Developing,Self-financing,Uruguay,URY,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,3355560
AMR,LACRO,High income,Member State,Developing,Self-financing,Uruguay,URY,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,3850000
AMR,LACRO,High income,Member State,Developing,Self-financing,Uruguay,URY,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,48000
AMR,LACRO,High income,Member State,Developing,Self-financing,Uruguay,URY,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,50400
AMR,LACRO,High income,Member State,Developing,Self-financing,Uruguay,URY,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,7354360
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,8700000
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,2469960
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1008000
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,471510
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,1062500
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,300000
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1000350
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,300000
AMR,LACRO,Middle income,Member State,Developing,AMC,Bolivia (Plurinational State of),BOL,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,15312320
AMR,LACRO,Middle income,Member State,Developing,AMC,Dominica,DMA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
AMR,LACRO,Middle income,Member State,Developing,AMC,Dominica,DMA,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,
AMR,LACRO,Middle income,Member State,Developing,AMC,Dominica,DMA,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
AMR,LACRO,Middle income,Member State,Developing,AMC,Dominica,DMA,2022-09-08T23:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,46800
AMR,LACRO,Middle income,Member State,Developing,AMC,Dominica,DMA,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,46800
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,1500000
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,20000
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1668000
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,96000
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,3000200
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,317070
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,33600
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,150000
AMR,LACRO,Middle income,Member State,Developing,AMC,El Salvador,SLV,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,5284870
AMR,LACRO,Middle income,Member State,Developing,AMC,Grenada,GRD,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,45600
AMR,LACRO,Middle income,Member State,Developing,AMC,Grenada,GRD,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
AMR,LACRO,Middle income,Member State,Developing,AMC,Grenada,GRD,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,SII - Covishield,
AMR,LACRO,Middle income,Member State,Developing,AMC,Grenada,GRD,2022-11-11T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
AMR,LACRO,Middle income,Member State,Developing,AMC,Grenada,GRD,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,29250
AMR,LACRO,Middle income,Member State,Developing,AMC,Grenada,GRD,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,74850
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,4200000
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,4400370
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,424800
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,117000
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,189600
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,477839
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,3000100
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,MULTILATERAL_OTHER,AstraZeneca,SII - Covishield,510400
AMR,LACRO,Middle income,Member State,Developing,AMC,Honduras,HND,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,13320109
AMR,LACRO,Middle income,Member State,Developing,AMC,Nicaragua,NIC,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,310000
AMR,LACRO,Middle income,Member State,Developing,AMC,Nicaragua,NIC,2022-06-05T23:00:00.000Z,DONATION,AstraZeneca,SII - Covishield,335000
AMR,LACRO,Middle income,Member State,Developing,AMC,Nicaragua,NIC,2022-06-05T23:00:00.000Z,DONATION,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,3000
AMR,LACRO,Middle income,Member State,Developing,AMC,Nicaragua,NIC,2022-06-05T23:00:00.000Z,NR,NR,All vaccine types,648000
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Lucia,LCA,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,24000
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Lucia,LCA,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,26400
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Lucia,LCA,2022-06-05T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,25000
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Lucia,LCA,2022-06-05T23:00:00.000Z,NR,NR,All vaccine types,75400
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,21600
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-07-06T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,24000
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-05-04T23:00:00.000Z,DONATION,Serum Institute of India,AstraZeneca - Vaxzevria,85600
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-07-06T23:00:00.000Z,DONATION,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,1820
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-07-06T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,40000
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,137420
AMR,LACRO,Middle income,Member State,Developing,AMC,Saint Vincent and the Grenadines,VCT,2022-07-06T23:00:00.000Z,OTHER,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,50000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,CanSino Biologicals,CanSino - Convidecia,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Argentina,ARG,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-05-04T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,SII - Covishield,67200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,100800
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,42000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,200000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,SII - Covishield,1000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,10000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,14800
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,286650
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Belize,BLZ,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,655250
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Brazil,BRA,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,200000970
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Brazil,BRA,2022-05-04T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,5073600
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Brazil,BRA,2022-05-04T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,842400
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Brazil,BRA,2022-05-04T23:00:00.000Z,NR,NR,All vaccine types,205916970
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,9997560
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,9000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,10000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,15000570
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,12000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,2066400
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,2217150
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,6619200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,1057600
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,2500000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,3500000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Colombia,COL,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,73958480
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Costa Rica,CRI,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,540000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Costa Rica,CRI,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,2174055
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Costa Rica,CRI,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,43200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Costa Rica,CRI,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,88800
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Costa Rica,CRI,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,40950
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Costa Rica,CRI,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,2887005
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,614000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,CanSino Biologicals,CanSino - Convidecia,800000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,4675125
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,13000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,336000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,420000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,101760
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,394950
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,1000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Ecuador,ECU,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,21341835
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,660000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,8000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,321600
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,403200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1533870
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,300000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,304000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,363100
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,5000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,6500060
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,200000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Guatemala,GTM,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,18590830
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,100000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,55200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,100620
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,MULTILATERAL_AFRICAN,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1900000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Jamaica,JAM,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,2211020
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,367200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,734400
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,6702930
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,36000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,148800
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,198900
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,503100
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Panama,PAN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,8691330
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,1000000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Julphar,Julphar - Hayat-Vax,250000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,934400
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,39600
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,DONATION,Bharat Biotech,Bharat - Covaxin,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,0
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Paraguay,PRY,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,2224000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-04-03T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,52800
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-04-03T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,SII - Covishield,50000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-09-08T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,307200
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-09-08T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,100000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-09-08T23:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,10000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-09-08T23:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,140400
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-09-08T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,51000
AMR,LACRO,Middle income,Member State,Developing,Self-financing,Suriname,SUR,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,608600
AMR,LACRO,Middle income,Member State,Least developed,AMC,Haiti,HTI,2022-04-03T23:00:00.000Z,COVAX_FACILITY,Vaxxinity Inc,Unknown Vaccine,
AMR,LACRO,Middle income,Member State,Least developed,AMC,Haiti,HTI,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,
AMR,LACRO,Middle income,Member State,Least developed,AMC,Haiti,HTI,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
AMR,LACRO,NA,Member State,Developing,Self-financing,Venezuela (Bolivarian Republic of),VEN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,250000
AMR,LACRO,NA,Member State,Developing,Self-financing,Venezuela (Bolivarian Republic of),VEN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,230000
AMR,LACRO,NA,Member State,Developing,Self-financing,Venezuela (Bolivarian Republic of),VEN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,480000
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,108000
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,151200
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,528320
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,231718
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,582870
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,300000
EMR,ESARO,Low income,Member State,Least developed,AMC,Somalia,SOM,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,1902108
EMR,MENA,High income,Member State,Developing,Self-financing,Qatar,QAT,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,122400
EMR,MENA,High income,Member State,Developing,Self-financing,Qatar,QAT,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,1999800
EMR,MENA,High income,Member State,Developing,Self-financing,Qatar,QAT,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,3799965
EMR,MENA,High income,Member State,Developing,Self-financing,Qatar,QAT,2022-03-03T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
EMR,MENA,High income,Member State,Developing,Self-financing,Qatar,QAT,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,5922165
EMR,MENA,High income,Member State,Developing,Self-financing,United Arab Emirates,ARE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
EMR,MENA,High income,Member State,Developing,Self-financing,United Arab Emirates,ARE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,
EMR,MENA,High income,Member State,Developing,Self-financing,United Arab Emirates,ARE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Julphar,Julphar - Hayat-Vax,
EMR,MENA,High income,Member State,Developing,Self-financing,United Arab Emirates,ARE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,
EMR,MENA,High income,Member State,Developing,Self-financing,United Arab Emirates,ARE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EMR,MENA,High income,Member State,Developing,Self-financing,United Arab Emirates,ARE,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1995000
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,100000
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Sputnik-Light,250000
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,7221640
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,203000
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Sinovac,Chumakov - Covi-Vac,1356000
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-06-05T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,203000
EMR,MENA,Low income,Member State,Developing,AMC,Syrian Arab Republic,SYR,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,11125640
EMR,MENA,Low income,Member State,Least developed,AMC,Yemen,YEM,2022-06-05T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,360000
EMR,MENA,Low income,Member State,Least developed,AMC,Yemen,YEM,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,SII - Covishield,360000
EMR,MENA,Low income,Member State,Least developed,AMC,Yemen,YEM,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,151200
EMR,MENA,Low income,Member State,Least developed,AMC,Yemen,YEM,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,360000
EMR,MENA,Low income,Member State,Least developed,AMC,Yemen,YEM,2022-09-08T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,356800
EMR,MENA,Low income,Member State,Least developed,AMC,Yemen,YEM,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1228000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,90000000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Bharat Biotech,Bharat - Covaxin,500000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,2000000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,12000000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,DOMESTIC,Instituto Finlay de Vacunas,Finlay - Soberana-02,8000000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,DOMESTIC,Shifa Pharmed,Shifa - COVIran Barakat,50000000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,DOMESTIC,Vaxine Pty Ltd,Vaxine-SpikoGen,6000000
EMR,MENA,Middle income,Member State,Developing,Self-financing,Iran (Islamic Republic of),IRN,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,168500000
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,124000
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,144000
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,151200
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,700000
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,3312000
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,968000
EMR,ROSA,Low income,Member State,Least developed,AMC,Afghanistan,AFG,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,5399200
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,CanSino Biologicals,CanSino - Convidecia,1659200
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,20550000
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-03-03T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1220000
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,34989200
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-04-03T23:00:00.000Z,OTHER,CanSino Biologicals,CanSino - Convidecia,60000
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,OTHER,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,12720000
EMR,ROSA,Middle income,Member State,Developing,AMC,Pakistan,PAK,2022-09-08T23:00:00.000Z,OTHER,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,60000
EUR,,Middle income,Territory or Area,,AMC,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),XKX,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1213290
EUR,,Middle income,Territory or Area,,AMC,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),XKX,2022-10-09T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,100800
EUR,,Middle income,Territory or Area,,AMC,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),XKX,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,638820
EUR,,Middle income,Territory or Area,,AMC,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),XKX,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,10000
EUR,,Middle income,Territory or Area,,AMC,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),XKX,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,94770
EUR,,Middle income,Territory or Area,,AMC,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),XKX,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,2057680
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,80000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-07-06T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1100000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-08-07T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,44400
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-08-07T23:00:00.000Z,DOMESTIC,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1250000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-07-06T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,40000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-07-06T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,150000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-09-08T23:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,150000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-10-09T23:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,259740
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Kyrgyzstan,KGZ,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,259740
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,0
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,DONATION,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Tajikistan,TJK,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,0
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,367200
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,705600
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,5073200
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1253070
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,159600
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,153600
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,586400
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,2626380
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,35002446
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,OTHER,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,500
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,13343580
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,OTHER,Serum Institute of India,SII - Covishield,500000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,AMC,Ukraine,UKR,2022-11-11T00:00:00.000Z,OTHER,Sinovac,Sinovac - CoronaVac,10233316
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Belarus,BLR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1884328
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Belarus,BLR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,811790
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Belarus,BLR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Sputnik-Light,249200
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Belarus,BLR,2022-11-11T00:00:00.000Z,DOMESTIC,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,4446847
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Belarus,BLR,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,7392165
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Belarus,BLR,2022-10-09T23:00:00.000Z,OTHER,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1000000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-06-05T23:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-09-08T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,100000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-09-08T23:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,121600
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-09-08T23:00:00.000Z,OTHER,AstraZeneca,AstraZeneca - Vaxzevria,1000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-09-08T23:00:00.000Z,OTHER,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,20300
EUR,CEE-CIS,Middle income,Member State,Economy in transition,No,Turkmenistan,TKM,2022-09-08T23:00:00.000Z,OTHER,State Research Center of Virology & Biotechnology,SRCVB - EpiVacCorona,300
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Azerbaijan,AZE,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,200000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Azerbaijan,AZE,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,8753710
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Azerbaijan,AZE,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,259200
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Azerbaijan,AZE,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,218790
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Azerbaijan,AZE,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,9431700
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,43200
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1700000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,506610
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,576810
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,1000000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,129600
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,30420
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,468000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Georgia,GEO,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,4454640
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Montenegro,MNE,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,200000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Montenegro,MNE,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,50000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Montenegro,MNE,2022-03-03T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,24000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Montenegro,MNE,2022-03-03T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,30000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Montenegro,MNE,2022-03-03T00:00:00.000Z,DONATION,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,4000
EUR,CEE-CIS,Middle income,Member State,Economy in transition,Self-financing,Montenegro,MNE,2022-03-03T00:00:00.000Z,NR,NR,All vaccine types,308000
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,5934447
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Curevac,Curevac - CVnCoV,3000000
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,2500000
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,8030551
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Novavax,Novavax - Covavax,1150000
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,33333789
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Sanofi Pasteur - GSK,Sanofi GSK - Vidprevtyn,2940000
EUR,Dev,High income,Member State,Developed economy,No,Austria,AUT,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,56888787
EUR,Dev,High income,Member State,Developed economy,No,Belgium,BEL,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Curevac,Curevac - CVnCoV,
EUR,Dev,High income,Member State,Developed economy,No,Belgium,BEL,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,7500000
EUR,Dev,High income,Member State,Developed economy,No,Belgium,BEL,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,5000000
EUR,Dev,High income,Member State,Developed economy,No,Belgium,BEL,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,5900000
EUR,Dev,High income,Member State,Developed economy,No,Belgium,BEL,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,15000000
EUR,Dev,High income,Member State,Developed economy,No,Belgium,BEL,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,33400000
EUR,Dev,High income,Member State,Developed economy,No,Czechia,CZE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,3000000
EUR,Dev,High income,Member State,Developed economy,No,Czechia,CZE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,2000000
EUR,Dev,High income,Member State,Developed economy,No,Czechia,CZE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,3977200
EUR,Dev,High income,Member State,Developed economy,No,Czechia,CZE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,14000000
EUR,Dev,High income,Member State,Developed economy,No,Czechia,CZE,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,22977200
EUR,Dev,High income,Member State,Developed economy,No,Denmark,DNK,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,5100000
EUR,Dev,High income,Member State,Developed economy,No,Denmark,DNK,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
EUR,Dev,High income,Member State,Developed economy,No,Denmark,DNK,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,8900000
EUR,Dev,High income,Member State,Developed economy,No,Denmark,DNK,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,8000000
EUR,Dev,High income,Member State,Developed economy,No,Denmark,DNK,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,22000000
EUR,Dev,High income,Member State,Developed economy,No,Estonia,EST,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,Dev,High income,Member State,Developed economy,No,Estonia,EST,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
EUR,Dev,High income,Member State,Developed economy,No,Estonia,EST,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,
EUR,Dev,High income,Member State,Developed economy,No,Estonia,EST,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,Dev,High income,Member State,Developed economy,No,Finland,FIN,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,Dev,High income,Member State,Developed economy,No,Finland,FIN,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
EUR,Dev,High income,Member State,Developed economy,No,Finland,FIN,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,
EUR,Dev,High income,Member State,Developed economy,No,Finland,FIN,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,Dev,High income,Member State,Developed economy,No,France,FRA,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,44000000
EUR,Dev,High income,Member State,Developed economy,No,France,FRA,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,30000000
EUR,Dev,High income,Member State,Developed economy,No,France,FRA,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,24000000
EUR,Dev,High income,Member State,Developed economy,No,France,FRA,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,49000000
EUR,Dev,High income,Member State,Developed economy,No,France,FRA,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,147000000
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,5000000
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,2000000
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,6513460
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,4309022
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,1723610
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,10874511
EUR,Dev,High income,Member State,Developed economy,No,Hungary,HUN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,30420603
EUR,Dev,High income,Member State,Developed economy,No,Ireland,IRL,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,Dev,High income,Member State,Developed economy,No,Ireland,IRL,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
EUR,Dev,High income,Member State,Developed economy,No,Ireland,IRL,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,
EUR,Dev,High income,Member State,Developed economy,No,Ireland,IRL,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,Dev,High income,Member State,Developed economy,No,Ireland,IRL,2022-05-04T23:00:00.000Z,NR,NR,All vaccine types,3267660
EUR,Dev,High income,Member State,Developed economy,No,Italy,ITA,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,Dev,High income,Member State,Developed economy,No,Italy,ITA,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
EUR,Dev,High income,Member State,Developed economy,No,Italy,ITA,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,
EUR,Dev,High income,Member State,Developed economy,No,Italy,ITA,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,Dev,High income,Member State,Developed economy,No,Italy,ITA,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Curevac,Curevac - CVnCoV,1380000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Novavax,Novavax - Covavax,633000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Sanofi Pasteur - GSK,Sanofi GSK - Vidprevtyn,1500000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,Valneva,Valneva - VLA2001,372000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,1860000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,700000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,517000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,9296000
EUR,Dev,High income,Member State,Developed economy,No,Lithuania,LTU,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,12373000
EUR,Dev,High income,Member State,Developed economy,No,Norway,NOR,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,3300000
EUR,Dev,High income,Member State,Developed economy,No,Norway,NOR,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,3400000
EUR,Dev,High income,Member State,Developed economy,No,Norway,NOR,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,4300000
EUR,Dev,High income,Member State,Developed economy,No,Norway,NOR,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,6000000
EUR,Dev,High income,Member State,Developed economy,No,Norway,NOR,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,17000000
EUR,Dev,High income,Member State,Developed economy,No,Slovenia,SVN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,525800
EUR,Dev,High income,Member State,Developed economy,No,Slovenia,SVN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,230400
EUR,Dev,High income,Member State,Developed economy,No,Slovenia,SVN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,392400
EUR,Dev,High income,Member State,Developed economy,No,Slovenia,SVN,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,2379780
EUR,Dev,High income,Member State,Developed economy,No,Slovenia,SVN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,3528380
EUR,Dev,High income,Member State,Developed economy,No,Spain,ESP,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,31555649
EUR,Dev,High income,Member State,Developed economy,No,Spain,ESP,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,17598400
EUR,Dev,High income,Member State,Developed economy,No,Spain,ESP,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,28012919
EUR,Dev,High income,Member State,Developed economy,No,Spain,ESP,2022-12-12T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,72215693
EUR,Dev,High income,Member State,Developed economy,No,Spain,ESP,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,149382661
EUR,Dev,High income,Member State,Developed economy,No,Sweden,SWE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,
EUR,Dev,High income,Member State,Developed economy,No,Sweden,SWE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Moderna,Moderna - Spikevax,
EUR,Dev,High income,Member State,Developed economy,No,Sweden,SWE,2022-11-11T00:00:00.000Z,MULTILATERAL_EU,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,Dev,High income,Member State,Developed economy,No,Sweden,SWE,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
EUR,Dev,High income,Member State,Developed economy,Self-financing,Andorra,AND,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,33000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Andorra,AND,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,12000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Andorra,AND,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,53430
EUR,Dev,High income,Member State,Developed economy,Self-financing,Andorra,AND,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,26400
EUR,Dev,High income,Member State,Developed economy,Self-financing,Andorra,AND,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,124830
EUR,Dev,High income,Member State,Developed economy,Self-financing,Monaco,MCO,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,76050
EUR,Dev,High income,Member State,Developed economy,Self-financing,Monaco,MCO,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,76050
EUR,Dev,High income,Member State,Developed economy,Self-financing,Monaco,MCO,2022-06-05T23:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,58500
EUR,Dev,High income,Member State,Developed economy,Self-financing,San Marino,SMR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,68000
EUR,Dev,High income,Member State,Developed economy,Self-financing,San Marino,SMR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,31590
EUR,Dev,High income,Member State,Developed economy,Self-financing,San Marino,SMR,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,99590
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,150000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,27500000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Novavax,Novavax - Covavax,1000000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,20000000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-08-07T23:00:00.000Z,MULTILATERAL_EU,Curevac,Curevac - CVnCoV,5000000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-10-09T23:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,5300000
EUR,Dev,High income,Member State,Developed economy,Self-financing,Switzerland,CHE,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,48650000
EUR,Dev,High income,Member State,Developing,Self-financing,Israel,ISR,2022-07-06T23:00:00.000Z,NR,NR,All vaccine types,11700000
EUR,Dev,High income,Member State,Developing,Self-financing,Israel,ISR,2022-09-08T23:00:00.000Z,OTHER,Moderna,Moderna - Spikevax,
EUR,Dev,High income,Member State,Developing,Self-financing,Israel,ISR,2022-09-08T23:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
EUR,Dev,High income,Member State,Developing,Self-financing,Israel,ISR,2022-10-09T23:00:00.000Z,OTHER,AstraZeneca,AstraZeneca - Vaxzevria,
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Anhui Zhifei Longcom Biopharmaceutical,Anhui ZL - Recombinant,
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,30298250
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,8200000
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,CanSino Biologicals,CanSino - Convidecia,
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,500000
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,21629010
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,Novavax - Covavax,
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,203807300
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-03-03T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,4965600
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,273234720
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,OTHER,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,
SEAR,EAPRO,Middle income,Member State,Developing,AMC,Indonesia,IDN,2022-11-11T00:00:00.000Z,OTHER,Moderna,Moderna - Spikevax,8800160
SEAR,EAPRO,Middle income,Member State,Developing,No,Thailand,THA,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,117000
SEAR,EAPRO,Middle income,Member State,Developing,No,Thailand,THA,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,3500000
SEAR,EAPRO,Middle income,Member State,Developing,No,Thailand,THA,2022-03-03T00:00:00.000Z,NR,NR,All vaccine types,3617000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,24000000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,AstraZeneca - Vaxzevria,13400000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,30000000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,3000000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-03-03T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,500000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-03-03T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,1500000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Myanmar,MMR,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,70400000
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Timor-Leste,TLS,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Timor-Leste,TLS,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Timor-Leste,TLS,2022-09-08T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Timor-Leste,TLS,2022-09-08T23:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,
SEAR,EAPRO,Middle income,Member State,Least developed,AMC,Timor-Leste,TLS,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,
SEAR,ROSA,Middle income,Member State,Developing,AMC,India,IND,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Bharat Biotech,Bharat - Covaxin,20000000
SEAR,ROSA,Middle income,Member State,Developing,AMC,India,IND,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,169000000
SEAR,ROSA,Middle income,Member State,Developing,AMC,India,IND,2022-03-03T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,9996000
SEAR,ROSA,Middle income,Member State,Developing,AMC,India,IND,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,1660000000
SEAR,ROSA,Middle income,Member State,Developing,AMC,India,IND,2022-09-08T23:00:00.000Z,OTHER,Bharat Biotech,Bharat - Covaxin,360000000
SEAR,ROSA,Middle income,Member State,Developing,AMC,India,IND,2022-09-08T23:00:00.000Z,OTHER,Serum Institute of India,SII - Covishield,1300000000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,700000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,100000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,12000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,112000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,5850
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,229320
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,12000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,250200
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,260000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Maldives,MDV,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,1681370
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,15000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,500000
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,OTHER,Gamaleya Research Institute,Gamaleya - Sputnik-Light,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
SEAR,ROSA,Middle income,Member State,Developing,AMC,Sri Lanka,LKA,2022-11-11T00:00:00.000Z,OTHER,Serum Institute of India,SII - Covishield,
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Serum Institute of India,SII - Covishield,7000000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,7202760
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,34878000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,7947240
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,22927320
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,5504000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,COVAX_FACILITY,Sinovac,Sinovac - CoronaVac,75010800
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-03-03T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,3300000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bangladesh,BGD,2022-09-08T23:00:00.000Z,NR,NR,All vaccine types,153470120
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,250000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,198900
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Bhutan,BTN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,448900
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Nepal,NPL,2022-03-03T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,1000000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Nepal,NPL,2022-03-03T00:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,800000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Nepal,NPL,2022-03-03T00:00:00.000Z,NR,NR,All vaccine types,2148000
SEAR,ROSA,Middle income,Member State,Least developed,AMC,Nepal,NPL,2022-03-03T00:00:00.000Z,OTHER,Serum Institute of India,SII - Covishield,348000
WPR,,High income,Territory or Area,,,"China, Macao SAR",MAC,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1000000
WPR,,High income,Territory or Area,,,"China, Macao SAR",MAC,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,400000
WPR,,High income,Territory or Area,,,"China, Macao SAR",MAC,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,1400000
WPR,,High income,Territory or Area,Developing,,French Polynesia,PYF,2022-03-03T00:00:00.000Z,DONATION,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
WPR,,High income,Territory or Area,Developing,,French Polynesia,PYF,2022-03-03T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
WPR,Dev,High income,Member State,Developed economy,Self-financing,Australia,AUS,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,256800000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Australia,AUS,2022-11-11T00:00:00.000Z,OTHER,AstraZeneca,AstraZeneca - Vaxzevria,53800000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Australia,AUS,2022-11-11T00:00:00.000Z,OTHER,Moderna,Moderna - Spikevax,26000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Australia,AUS,2022-11-11T00:00:00.000Z,OTHER,Novavax,Novavax - Covavax,51000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Australia,AUS,2022-11-11T00:00:00.000Z,OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,126000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Japan,JPN,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,50000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Japan,JPN,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,144000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Japan,JPN,2022-03-03T00:00:00.000Z,DOMESTIC,AstraZeneca,AstraZeneca - Vaxzevria,120000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,Japan,JPN,2022-03-03T00:00:00.000Z,DOMESTIC,Novavax,Novavax - Covavax,
WPR,Dev,High income,Member State,Developed economy,Self-financing,Japan,JPN,2022-03-03T00:00:00.000Z,NR,NR,All vaccine types,314000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,New Zealand,NZL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,7800000
WPR,Dev,High income,Member State,Developed economy,Self-financing,New Zealand,NZL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,2000000
WPR,Dev,High income,Member State,Developed economy,Self-financing,New Zealand,NZL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Novavax,Novavax - Covavax,10720000
WPR,Dev,High income,Member State,Developed economy,Self-financing,New Zealand,NZL,2022-10-09T23:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,15580000
WPR,Dev,High income,Member State,Developed economy,Self-financing,New Zealand,NZL,2022-10-09T23:00:00.000Z,NR,NR,All vaccine types,36100000
WPR,Dev,High income,Territory or Area,Developing,,"China, Hong Kong SAR",HKG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
WPR,Dev,High income,Territory or Area,Developing,,"China, Hong Kong SAR",HKG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,
WPR,Dev,High income,Territory or Area,Developing,,"China, Hong Kong SAR",HKG,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,45600
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,200400
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,300690
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,100800
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,DONATION,Moderna,Moderna - Spikevax,
WPR,EAPRO,High income,Member State,Developing,Self-financing,Brunei Darussalam,BRN,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,647490
WPR,EAPRO,High income,Member State,Developing,Self-financing,Nauru,NRU,2022-04-03T23:00:00.000Z,NR,NR,All vaccine types,17200
WPR,EAPRO,High income,Member State,Developing,Self-financing,Nauru,NRU,2022-04-03T23:00:00.000Z,OTHER,AstraZeneca,AstraZeneca - Vaxzevria,7200
WPR,EAPRO,High income,Member State,Developing,Self-financing,Nauru,NRU,2022-04-03T23:00:00.000Z,OTHER,Serum Institute of India,SII - Covishield,10000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Micronesia (Federated States of),FSM,2022-03-03T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,10
WPR,EAPRO,Middle income,Member State,Developing,AMC,Micronesia (Federated States of),FSM,2022-03-03T00:00:00.000Z,NR,NR,All vaccine types,10
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,120000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,48000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,64800
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1214460
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,300000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,150000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,MULTILATERAL_OTHER,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,4000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,MULTILATERAL_OTHER,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,1765530
WPR,EAPRO,Middle income,Member State,Developing,AMC,Mongolia,MNG,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,7662790
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,146400
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,116400
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,604800
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,133000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,8480
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,186500
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,200000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-04-03T23:00:00.000Z,MULTILATERAL_EU,AstraZeneca,AstraZeneca - Vaxzevria,8000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Papua New Guinea,PNG,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,1249180
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,6000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-06-05T23:00:00.000Z,BILATERAL_AGREEMENT,Novavax,Novavax - Covavax,10000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,10000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Moderna,Moderna - Spikevax,13000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,40001130
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,51130400
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Moderna,Moderna - Spikevax,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,DONATION,Gamaleya Research Institute,Gamaleya - Sputnik-Light,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,DONATION,Julphar,Julphar - Hayat-Vax,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-05-04T23:00:00.000Z,MULTILATERAL_OTHER,Novavax,Novavax - Covavax,15000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,MULTILATERAL_OTHER,AstraZeneca,AstraZeneca - Vaxzevria,17000000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,MULTILATERAL_OTHER,Moderna,Moderna - Spikevax,7016760
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,MULTILATERAL_OTHER,Sinovac,Sinovac - CoronaVac,900000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Philippines,PHL,2022-12-12T00:00:00.000Z,NR,NR,All vaccine types,139048290
WPR,EAPRO,Middle income,Member State,Developing,AMC,Samoa,WSM,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,112000
WPR,EAPRO,Middle income,Member State,Developing,AMC,Samoa,WSM,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,55860
WPR,EAPRO,Middle income,Member State,Developing,AMC,Samoa,WSM,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,167860
WPR,EAPRO,Middle income,Member State,Developing,AMC,Tonga,TON,2022-04-03T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,43200
WPR,EAPRO,Middle income,Member State,Developing,AMC,Tonga,TON,2022-04-03T23:00:00.000Z,NR,NR,All vaccine types,43200
WPR,EAPRO,Middle income,Member State,Developing,AMC,Viet Nam,VNM,2022-03-03T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,918800
WPR,EAPRO,Middle income,Member State,Developing,AMC,Viet Nam,VNM,2022-03-03T00:00:00.000Z,NR,NR,All vaccine types,918800
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,AstraZeneca,AstraZeneca - Vaxzevria,6400000
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,CanSino Biologicals,CanSino - Convidecia,3500000
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,44799300
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,7300000
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,13100000
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,1387200
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,DONATION,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,DONATION,Sinovac,Sinovac - CoronaVac,
WPR,EAPRO,Middle income,Member State,Developing,No,Malaysia,MYS,2022-11-11T00:00:00.000Z,NR,NR,All vaccine types,76486500
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Cambodia,KHM,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1000000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Cambodia,KHM,2022-05-04T23:00:00.000Z,BILATERAL_AGREEMENT,Sinovac,Sinovac - CoronaVac,5500000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Cambodia,KHM,2022-05-04T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,SII - Covishield,
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Cambodia,KHM,2022-04-03T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,1700000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Cambodia,KHM,2022-05-04T23:00:00.000Z,NR,NR,All vaccine types,6500000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,COVAX_FACILITY,AstraZeneca,AstraZeneca - Vaxzevria,616820
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,COVAX_FACILITY,Janssen Pharmaceuticals,Janssen - Ad26.COV 2-S,1008000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,COVAX_FACILITY,Pfizer BioNTech,Pfizer BioNTech - Comirnaty,100620
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,COVAX_FACILITY,Serum Institute of India,SII - Covishield,132000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,DONATION,AstraZeneca,AstraZeneca - Vaxzevria,415000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,DONATION,Beijing Bio-Institute Biological Products (CNBG),Beijing CNBG - BBIBP-CorV,3302000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,DONATION,Gamaleya Research Institute,Gamaleya - Gam-Covid-Vac,1000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,DONATION,Serum Institute of India,SII - Covishield,1000
WPR,EAPRO,Middle income,Member State,Least developed,AMC,Lao People's Democratic Republic,LAO,2022-08-07T23:00:00.000Z,NR,NR,All vaccine types,5576440
